Tinea Corporis
📧 Sign up to get email alerts when something new happens for Tinea Corporis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-01FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2014-11-24FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)
The FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) by Voyant Beauty Inc., indicating regulatory cl…
-
FDA approval · 2014-10-10FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc.
-
FDA approval · 2014-09-24FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)
FDA approves a supplemental application for Naftin (naftifine hydrochloride) by Legacy Pharma USA Inc., resulting in labeling updates throug…
-
FDA approval · 2014-01-09FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC via an Original Application.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-11-14FDA Approved: LUZU — Original Application (Bausch Health US, LLC)
FDA approved LUZU (luliconazole) as a topical antifungal for the treatment of superficial fungal infections of the skin caused by dermatophy…
-
FDA approval · 2013-11-13FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.
-
FDA approval · 2013-06-27FDA Approved: NAFTIN — Original Application (Legacy Pharma USA Inc.)
FDA approved NAFTIN (naftifine hydrochloride) under an Original Application from Legacy Pharma USA Inc. for topical treatment of dermatophyt…
-
FDA approval · 2013-05-21FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Ciclopirox Olamine from Cosette Pharmaceuticals, resulting in updated labeling for its topical a…
-
FDA approval · 2013-02-05FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for terbinafine hydrochloride products from NorthStar Rx LLC. This action confirms continued ava…
-
FDA approval · 2013-01-03FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).
-
FDA approval · 2012-10-22FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sigmapharm Laboratories, LLC)
FDA approved the original application (ANDA) for ULTRAMICROSIZE GRISEOFULVIN from Sigmapharm Laboratories, LLC.
-
FDA approval · 2012-06-28FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Dr.Reddys Laboratories Limited)
FDA approved a supplemental application for terbinafine hydrochloride tablets (250 mg) from Dr. Reddy's Laboratories Limited, authorizing a …
-
FDA approval · 2012-04-10FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approves Breckenridge Pharmaceutical's supplemental application for terbinafine hydrochloride, a generic antifungal, to market an additi…
-
FDA approval · 2012-03-20FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)
FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) with Voyant Beauty as the manufacturer.
-
FDA approval · 2012-03-20FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc., representing an additi…
-
FDA approval · 2012-02-29FDA Approved: CICLOPIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's ciclopirox as a generic product under an original ANDA application.
-
FDA approval · 2011-12-14FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine Hydrochloride by Bionpharma Inc., signaling an approval of a supplemental submission…
-
FDA approval · 2011-09-21FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Terbinafine hydrochloride from NorthStar Rx LLC, updating the generic product's approval.
-
FDA approval · 2011-02-23FDA Approved: CICLOPIROX — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's Ciclopirox as an original ANDA, authorizing the generic topical antifungal product.
-
FDA approval · 2011-02-04FDA Approved: KETOCONAZOLE — Supplemental Application (Northstar Rx LLC)
The FDA approved a supplemental application for Ketoconazole submitted by Northstar Rx LLC.
-
FDA approval · 2010-12-20FDA Approved: CICLOPIROX OLAMINE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approves the original ANDA for Ciclopirox Olamine topical product from Cosette Pharmaceuticals, a generic antifungal treatment. The prod…
-
FDA approval · 2010-10-08FDA Approved: GRISEOFULVIN — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Griseofulvin from Cosette Pharmaceuticals in an Original Application (ANDA065438). This approval provides a generic Griseofulvi…
-
FDA approval · 2010-09-17FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)
FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.
-
FDA approval · 2010-08-03FDA Approved: CLOTRIMAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a generic clotrimazole product under an original ANDA from Glenmark Pharmaceuticals Inc., USA.